
Regulatory16 Nov 2026, 07:30 pm
Orchid Pharma Board Notes ₹2000 Fine for Delayed Annual Report Filing
AI Summary
Orchid Pharma Ltd's Board of Directors acknowledged notices from the National Stock Exchange and BSE imposing a fine of ₹2,000 each for a one-day delay in filing the Annual Report for FY 2025-26. The company has paid the fines, totaling ₹4,000 plus GST. The Board has directed management to enhance internal compliance monitoring to prevent future occurrences of such delays in statutory and regulatory filings.
Key Highlights
- Board noted fines from NSE and BSE for delayed annual report filing.
- Total fine of ₹4,000 plus GST was levied for a one-day delay.
- Company has paid the imposed fines.
- Management advised to strengthen compliance monitoring.
- Focus on timely submission of future regulatory filings.
Price Impact
More from ORCHPHARMA